{"url_path":"/sec/mchx/proxy/2026-05-13/000119312526221700","section_key":"body","section_title":"DEFA14A body","topic":"sec","document":{"doc_type":"DEFA14A","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1224133/0001193125-26-221700-index.html","accession_number":"0001193125-26-221700","cik":"0001224133","ticker":"MCHX","issuer_name":"MARCHEX INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1224133/0001193125-26-221700-index.html","primary_entity_key":"0001224133","primary_entity_name":"MARCHEX INC"},"word_count":623,"has_tables":true,"body_markdown":"DEFA14A\n1\ndefa14a_-_q1_2026_earnin.htm\nDEFA14A\n\nDEFA14A\n\n \n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWASHINGTON, D.C. 20549\n\nFORM 8-K\n\nCURRENT REPORT\n\nPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934\n\nDate of Report (Date of earliest event reported): May 13, 2026\n\nMarchex, Inc.\n\n(Exact name of Registrant as Specified in its Charter)\n\nDelaware\n\n000-50658\n\n35-2194038\n\n(State or other jurisdiction\n\nof incorporation)\n\n(Commission File Number)\n\n(IRS Employer\n\nIdentification No.)\n\n \n\n1448 NW Market St, Suite 500,\n\nSeattle, WA\n\n98107\n\n(Address of principal executive offices)\n\n(Zip Code)\n\nRegistrant’s Telephone Number, Including Area Code: (206) 331-3300\n\nNot Applicable\n\n(Former name or former address, if changed since last report)\n\nCheck the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):\n\n☐\n\nWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n☒\n\nSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n☐\n\nPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n☒\n\nPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\n \n\nTrading\n\nSymbol(s)\n\n \n\nName of each exchange on which registered\n\nClass B Common Stock, par value $0.01 per share\n\n \n\nMCHX\n\n \n\nThe Nasdaq Global Select Market\n\nIndicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).\n\nEmerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nItem 2.02 Results of Operations and Financial Condition.\n\nOn May 13, 2026, Marchex, Inc. (“Marchex” or the \"Company\") is issuing an Earnings Release and holding a conference call regarding its financial results for the first quarter ended March 31, 2026 (the “Earnings Release”). The full text of the Earnings Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.\n\nThe information in this Item 2.02 (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.\n\nMarchex is referencing non-generally accepted accounting principles (\"GAAP\") financial information in both the Earnings Release and on the conference call. A reconciliation of these non-GAAP financial measures to the comparable GAAP financial measures is contained in the attached Earnings Release. Disclosures regarding definitions of these financial measures used by Marchex and why Marchex’s management believes these financial measures provide useful information to investors is also included in the Earnings Release.\n\nItem 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits.\n\nExhibit\n\nNo.\n\nDescription\n\n \n\n \n\n99.1\n\n[Earnings Release of Marchex, dated May 13, 2026](mchx-ex99_1.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, Marchex has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \n\nMARCHEX, INC.\n\n \n\n \n\nDate: May 13, 2026\n\nBy:\n\n/S/ BRIAN NAGLE\n\n \n\nName:\n\nBrian Nagle\n\n \n\nTitle:\n\nChief Financial Officer (\"CFO\")\n\n(Principal Financial Officer and Principal Accounting Officer)"}